Compare ADMA Biologics Inc (ADMA) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs J B Hunt Transport Services Inc — how do they compare? ADMA Biologics Inc trades at $9.18 (market cap $2.13B), while J B Hunt Transport Services Inc trades at $275.5 (market cap $25.93B). The key difference: J B Hunt Transport Services Inc is far larger — about 12.2× ADMA Biologics Inc's market cap, and J B Hunt Transport Services Inc pays a 0.65% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | JBHT | |
|---|---|---|
Market Cap | $2.13B | $25.93B |
Sector | Health | Industrials |
52-Week High | $20.38 | $290.07 |
52-Week Low | $7.60 | $130.65 |
Enterprise Value | $2.20B | $27.23B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
JBHT trades at $275.00, down 3.79% over 24 hours, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported revenue of $12.00 billion in 2025 with a net income margin of 5.13%, and has beaten earnings estimates for the last three quarters. Recent news highlights its participation in industry conferences and positive analyst coverage amid a improving freight scenario.
The outlook for JBHT is supported by consistent earnings beats and a favorable analyst consensus, though high valuation ratios and exposure to freight market cyclicality present risks. Upside potential exists if the company maintains operational efficiency and capitalizes on industry tailwinds, but investors should weigh elevated P/E and P/B multiples against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
